Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Journal of Managed Care Pharmacy : JMCP|March 16, 2005
Relationship of total health care charges to selective serotonin reuptake inhibitor utilization patterns including the length of antidepressant therapy--results from a managed care administrative claims databaseMichael T Eaddy, Benjamin G Druss, Matthew W Sarnes, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2007
Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinomaDavid M Schuster, John R Votaw, Peter T Nieh, et al.Current Medical Research and Opinion|October 22, 2005
Differences in compliance patterns across the selective serotonin reuptake inhibitors (SSRIs)Matthew S Keene, Michael T Eaddy, Robert P Mauch, et al.Cancer Detection and Prevention|July 18, 2006
The value of digital rectal examination as a predictor of prostate cancer diagnosis among United States Veterans referred for prostate biopsyMuta M Issa, Witold Zasada, Kevin Ward, et al.Seminars in Nuclear Medicine|November 29, 2011
Guidance document for structured reporting of diuresis renographyAndrew T Taylor, M Donald Blaufox, Diego De Palma, et al.Urology|July 25, 2016
Implementation of a Tele-urology Program for Outpatient Hematuria Referrals: Initial Results and Patient SatisfactionIlan J Safir, Salil Gabale, Samuel A David, et al.JAMA|January 13, 2011
Behavioral therapy with or without biofeedback and pelvic floor electrical stimulation for persistent postprostatectomy incontinence: a randomized controlled trialPatricia S Goode, Kathryn L Burgio, Theodore M Johnson, et al.Molecular Imaging and Biology|May 19, 2009
Initial experience with the radiotracer anti-1-amino-3-[18F]Fluorocyclobutane-1-carboxylic acid (anti-[ 18F]FACBC) with PET in renal carcinomaDavid M Schuster, Jonathon A Nye, Peter T Nieh, et al.Implementation Science Communications|April 8, 2025
Integration and evaluation of implementation strategies to improve guideline-concordant bladder cancer surveillance: a prospective observational studyLisa Zubkoff, A Aziz Ould Ismail, Laura Jensen, et al.Proceedings of the National Academy of Sciences of the United States of America|January 14, 2005
mtDNA mutations increase tumorigenicity in prostate cancerJohn A Petros, Amanda K Baumann, Eduardo Ruiz-Pesini, et al.Pageof 7